Kv3.1 Protein

📖 Wiki Page

protein936 wordssynced 2026-04-02

Kv3.1 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Kv3.1 Protein</th>
</tr>
<tr>
<td class="label">Activation voltage</td>
<td>+10 to +30 mV</td>
</tr>
<tr>
<td class="label">Deactivation time</td>
<td>2-5 ms</td>
</tr>
<tr>
<td class="label">Activation time</td>
<td>1-2 ms</td>
</tr>
<tr>
<td class="label">Conductance</td>
<td>30-40 pS</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Activators</td>
<td>Enhance channel opening</td>
</tr>
<tr>
<td class="label">Blockers</td>
<td>Reduce channel activity</td>
</tr>
<tr>
<td class="label">Modulators</td>
<td>Allosteric regulation</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Viral vector delivery</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Kv3.1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Kv3.1 (KCNC1) is a voltage-gated potassium channel subunit that enables fast-spiking interneurons to fire at high frequencies without adaptation. It is characterized by rapid activation and deactivation kinetics, making it essential for precise temporal coding in neuronal circuits.

...

Kv3.1 Protein

Introduction

Kv3.1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The Kv3.1 channel, encoded by the KCNC1 gene, is a member of the Shaw-like potassium channel family (Kv3). These channels are distinguished by their unique biophysical properties, including depolarized voltage dependence and fast gating kinetics, which allow [neurons](/entities/neurons) to fire action potentials at frequencies exceeding 100 Hz without frequency-dependent depression.

Gene and Protein Structure

The KCNC1 gene is located on chromosome 11p15.5 and consists of 7 exons spanning approximately 12 kb. The protein product is 526 amino acids in length with a molecular weight of approximately 58 kDa.

Kv3.1 contains six transmembrane domains (S1-S6), with the S4 segment serving as the voltage sensor. The pore region is formed between S5 and S6 helices, containing the signature potassium channel selectivity filter (GYG). The cytoplasmic N- and C-termini contain sites for regulatory modifications including phosphorylation and protein-protein interactions.

Expression Pattern

Kv3.1 is predominantly expressed in fast-spiking interneurons throughout the central nervous system. High expression is observed in:

Cortical interneurons: Parvalbumin-positive (PV+) fast-spiking interneurons in all cortical layers
Hippocampal interneurons: PV+ basket cells and axo-axonic cells
Striatal interneurons: Fast-spiking PV+ interneurons
Thalamic reticular nucleus: Nucleus of the optic tract neurons
Cerebellar interneurons: Molecular layer interneurons and Golgi cells
Brainstem: Auditory brainstem neurons including bushy cells of the cochlear nucleus

In the human brain, Kv3.1 expression is particularly enriched in the cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and thalamus, regions critically involved in cognitive processing and sensory integration.

Molecular Function

Biophysical Properties

Kv3.1 channels exhibit several distinctive biophysical characteristics:

Role in Fast-Spiking

Kv3.1 channels enable fast-spiking interneurons to maintain high-frequency firing through:

Rapid repolarization: Fast activation and deactivation allow quick membrane potential reset after action potentials

Reduced spike frequency adaptation: Minimal use-dependent depression during sustained firing

Precise temporal precision: Enables accurate timing of inhibitory outputs

Metabolic efficiency: Reduced calcium entry through voltage-gated calcium channels due to brief action potentials

Protein-Protein Interactions

Kv3.1 interacts with several regulatory proteins:

KChiP1-3: K+ channel interacting proteins that modulate channel trafficking and gating
DARP32: Dopamine- and cAMP-regulated phosphoprotein, regulates Kv3.1 phosphorylation
AKAP79/150: A-kinase anchoring proteins that target PKA to regulate channel activity
Filamin A: Cytoskeletal protein that influences channel localization

Role in Neurodegeneration

Alzheimer's Disease

In AD, Kv3.1 dysfunction may contribute to:

Excitatory/inhibitory imbalance: Loss of fast-spiking interneurons disrupts cortical inhibition
Network oscillations: Impaired gamma oscillations (30-80 Hz) observed in AD models
Synaptic plasticity deficits: Altered short-term plasticity in inhibitory circuits

Parkinson's Disease

Kv3.1 channels in the basal ganglia are affected in PD:

Striatal interneuron dysfunction: Altered firing patterns in PV+ interneurons
Beta oscillations: Pathological synchronization in the 13-30 Hz range
Therapeutic implications: Kv3.1 modulators may restore normal firing patterns

Epilepsy

KCNC1 mutations cause progressive myoclonus epilepsy (PME):

Dominant-negative effects: Mutations disrupt channel function
Gain-of-function: Some mutations cause excessive neuronal inhibition
Therapeutic targeting: Kv3.1 activators may restore normal excitability

Ataxia

KCNC1 mutations are associated with cerebellar ataxia:

Purkinje neuron dysfunction: Impaired firing precision
Motor coordination deficits: Altered cerebellar output
Therapeutic approaches: Gene therapy and small molecule modulators

Therapeutic Implications

Drug Development Targets

Kv3.1 channels represent promising therapeutic targets:

Clinical Pipeline

Retigabine: Kv3.1/3.2 activator (approved for epilepsy, withdrawn)
Pyrazolopyrimidines: Novel Kv3.1 activators in preclinical development
AAV vectors: Gene therapy approaches for KCNC1 mutations

Animal Models

Knockout Studies

Kv3.1 KO mice: Show impaired fast-spiking, ataxia, and premature death
Conditional KO: Region-specific knockouts reveal circuit-specific functions
Humanized mice: Expressing disease-associated KCNC1 mutations

Disease Models

AD models: [Amyloid-beta](/proteins/amyloid-beta) exposure reduces Kv3.1 expression
PD models: 6-OHDA lesion alters Kv3.1 function in striatum
Epilepsy models: Kv3.1 mutations cause spontaneous seizures

Research Directions

Current research focuses on:

Structure-function studies: Cryo-EM structures of Kv3.1 in various states

Circuit-specific targeting: Developing region-selective modulators

Gene therapy: AAV-delivered KCNC1 for channelopathies

Biomarkers: Kv3.1 expression as a biomarker for interneuron health

Background

The study of Kv3.1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[1]: https://pubmed.ncbi.nlm.nih.gov/23400010/ PMID: 23400010(https://pubmed.ncbi.nlm.nih.gov/23400010/)
[2]: https://pubmed.ncbi.nlm.nih.gov/24563466/ PMID: 24563466(https://pubmed.ncbi.nlm.nih.gov/24563466/)
[3]: https://pubmed.ncbi.nlm.nih.gov/25849640/ PMID: 25849640(https://pubmed.ncbi.nlm.nih.gov/25849640/)
[4]: https://pubmed.ncbi.nlm.nih.gov/27426723/ PMID: 27426723(https://pubmed.ncbi.nlm.nih.gov/27426723/)
[5]: https://pubmed.ncbi.nlm.nih.gov/28645618/ PMID: 28645618(https://pubmed.ncbi.nlm.nih.gov/28645618/)
[6]: https://pubmed.ncbi.nlm.nih.gov/31837645/ PMID: 31837645(https://pubmed.ncbi.nlm.nih.gov/31837645/)
[7]: https://pubmed.ncbi.nlm.nih.gov/32974211/ PMID: 32974211(https://pubmed.ncbi.nlm.nih.gov/32974211/)
[8]: https://pubmed.ncbi.nlm.nih.gov/34567890/ PMID: 34567890(https://pubmed.ncbi.nlm.nih.gov/34567890/)

External Links

[UniProt: KCNC1](https://www.uniprot.org/uniprot/P48547)
[PDB: KCNC1](https://www.rcsb.org/structure/5W2Y)
[GeneCards: KCNC1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNC1)
[NCBI Gene: KCNC1](https://www.ncbi.nlm.nih.gov/gene/3748)

📖 View canonical wiki page →

Kv3.1 Protein

Kv3.1 Protein

Introduction

Overview

Kv3.1 Protein

Introduction

Overview

Gene and Protein Structure

Expression Pattern

Molecular Function

Biophysical Properties

Role in Fast-Spiking

Protein-Protein Interactions

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Ataxia

Therapeutic Implications

Drug Development Targets

Clinical Pipeline

Animal Models

Knockout Studies

Disease Models

Research Directions

Background

References

See Also

External Links